Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial-Reference-Cited by-同舟云学术

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial

Published:2016-08-25 Issue:2 Volume:28 Page:187-193
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Koh Jin-Sin¹,Park Yongwhi²,Tantry Udaya S.³,Ahn Jong-Hwa²,Kang Min Gyu¹,Kim Kyehwan¹,Jang Jeong Yoon²,Park Hyun Woong¹,Park Jeong Rang¹,Hwang Seok-Jae¹,Kwak Choong Hwan²,Hwang Jin-Yong¹,Gurbel Paul A.³,Jeong Young-Hoon²⁴

Affiliation:

1. Department of Internal Medicine, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea

2. Department of Internal Medicine, Gyeongsang National University School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea

3. Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA

4. Institute of the Health Sciences, Gyeongsang National University, Jinju, Republic of Korea

Funder

Hanmi Pharmaceutical Co., Ltd.

National Research Foundation

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2016.1206197

Reference32 articles.